Table 3: The
distribution of cases according to tumor type and their immunoreactive
features**.
|
Type |
n |
% |
PAX8 |
WT1 |
CD56 |
BER-EP4 |
ER |
|||||
|
n |
% |
N |
% |
n |
% |
n |
% |
n |
% |
|||
|
SC |
35 |
50.0 |
25 |
71.4 |
26 |
74.2 |
11 |
31.4 |
30 |
85.7 |
28 |
80.0 |
|
EC |
31 |
44.3 |
13 |
42.0 |
0 |
0.0 |
2 |
6.5 |
28 |
90.4 |
26 |
83.9 |
|
MM |
4 |
5.7 |
1 |
25.0 |
2 |
50.0 |
0 |
0.0 |
0 |
0.0 |
0 |
0.0 |
|
Total |
70 |
100.0 |
39 |
55.7 |
28 |
40.0 |
13 |
18.6 |
58 |
82.9 |
54 |
77.1 |
|
Result |
X2
= 7.41 |
X2
= 37.97 |
X2
= 7.74 |
X2
= 22.75 |
X2
= 14.45 |
|||||||
|
*p
= 0.025 |
*p
= 0.001 |
*p
= 0.021 |
*p
= 0.001 |
*p
= 0.001 |
||||||||
*significant if p < 0.05; **None
of the tumors react with desmin.